Amlodipine Besylate
- Product NDC
- 67544-993
- 11-digit product format
- 675440993
- Labeler code
- 67544
- Product ID
- 67544-993_59f698be-ad3d-4c46-b99a-e381c7b4100d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- amlodipine besylate
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Application
- ANDA076418
- Marketing category
- ANDA
- Marketing start
- 2005-10-03
- Marketing end
- 0000-00-00
- Substance
- AMLODIPINE BESYLATE
- Active strength
- 10 mg/1
- Pharmacologic classes
- Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [CS]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status.
Dataset, Scope, Product NDC table| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|
| excluded product | product | 67544-993 | | D | Discontinued by firm | | 2026-07-31 |
| excluded package | package | 67544-993 | 67544-993-15 | D | Discontinued by firm | | 2026-07-31 |
| excluded package | package | 67544-993 | 67544-993-30 | D | Discontinued by firm | | 2026-07-31 |
| excluded package | package | 67544-993 | 67544-993-45 | D | Discontinued by firm | | 2026-07-31 |
| excluded package | package | 67544-993 | 67544-993-60 | D | Discontinued by firm | | 2026-07-31 |
Orange Book products#
Application-product, Trade name, Ingredient table| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|
| A076418-001 | AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | EQ 2.5MG BASE | TABLET / ORAL | | | 2005-10-03 |
| A076418-002 | AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | EQ 5MG BASE | TABLET / ORAL | | | 2005-10-03 |
| A076418-003 | AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | EQ 10MG BASE | TABLET / ORAL | | | 2005-10-03 |